InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Chang David D, Chairman & CEO. Director active across 2 companies, notably Allogene Therapeutics, Inc.. In total, 12 disclosures have been published. Split: 0 buy · 5 sells. Total volume traded: €573k. Activity tracked since 24 May 2021. The latest transaction was disclosed on 16 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Chang David D is President-CEO and the indicated transaction pattern is selling across the 12 reported filings. In the 12 observed filings between 2021-05-26 and 2026-03-18, sales amount to EUR 572856 and the largest reported filings include EUR 920151.0817044046 on 2024-05-20, EUR 408862.1354921189 on 2021-05-26, and EUR 211031.7679100638 on 2024-03-18, all at Allogene Therapeutics, Inc.